Corporate digest
Tianjin Zhong Xin Pharmaceutical Group Corp
TIANJIN Zhong Xin Pharmaceutical Group Corp's controlling shareholder plans to carry out a mixed-ownership reform amid a Communist drive to reform state-owned enterprises, the Singapore-listed firm said on Tuesday.
But it added that Tianjin Pharmaceutical Group, which owns a 43.1 per cent stake, has not finished works such as the audit and valuation of assets and "significant uncertainties" still hang over the proposed reform.
TRENDING NOW
Knight Frank Singapore CEO Galven Tan resigns after 2.5 years at helm
ABSD deadline extended to up to 7 years for developers of large en bloc sites to encourage reuse of land
15-month wait-out curb lifted for private property owners buying HDB resale flats
Philippines’ income upgrade hides grim reality for most Filipinos